| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of General Virology, Vol 78, 2209-2215, Copyright © 1997 by Society for General Microbiology
ARTICLES |
Z Wang, N Christensen, JT Schiller and J Dillner
Microbiology and Tumorbiology Center, Karolinska Institute, Stockholm, Sweden.
A type-specific and neutralizing mouse MAb (V5) against human papillomavirus (HPV) type 16 capsids was found to block the serological reactivity of human sera with the corresponding capsids. Out of 352 human serum samples tested for the presence of IgG against HPV-16, more than 75% of reactive sera were completely blocked by the V5 antibody. Type-specific MAbs against HPV-6, -18 and -33 were also found to block serological reactivity with capsids of the corresponding HPV types for the majority of reactive human sera. The results suggest that most antibodies in human sera that are reactive with intact HPV capsids recognize the same or closely related major antigenic determinant(s).
This article has been cited by other articles:
|
|
 |
|
  P. M. Day, R. Gambhira, R. B. S. Roden, D. R. Lowy, and J. T. Schiller Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies J. Virol., May 1, 2008; 82(9): 4638 - 4646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Z. Rizk, N. D. Christensen, K. M. Michael, M. Muller, P. Sehr, T. Waterboer, and M. Pawlita Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types J. Gen. Virol., January 1, 2008; 89(1): 117 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Day, C. D. Thompson, C. B. Buck, Y.-Y. S. Pang, D. R. Lowy, and J. T. Schiller Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of Inhibition J. Virol., August 15, 2007; 81(16): 8784 - 8792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ryding, L. Dahlberg, M. Wallen-Ohman, and J. Dillner Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles J. Gen. Virol., March 1, 2007; 88(3): 792 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Aires, A. M. Cianciarullo, S. M. Carneiro, L. L. Villa, E. Boccardo, G. Perez-Martinez, I. Perez-Arellano, M. L. S. Oliveira, and P. L. Ho Production of Human Papillomavirus Type 16 L1 Virus-Like Particles by Recombinant Lactobacillus casei Cells Appl. Envir. Microbiol., January 1, 2006; 72(1): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dias, J. Van Doren, S. Schlottmann, S. Kelly, D. Puchalski, W. Ruiz, P. Boerckel, J. Kessler, J. M. Antonello, T. Green, et al. Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18 Clin. Vaccine Immunol., August 1, 2005; 12(8): 959 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Orozco, J. J. Carter, L. A. Koutsky, and D. A. Galloway Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers J. Virol., August 1, 2005; 79(15): 9503 - 9514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, M. Sapp, N. D. Christensen, and J. Dillner Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology J. Gen. Virol., January 1, 2005; 86(1): 65 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rocha-Zavaleta, J. P. Ambrosio, M. d. L. Mora-Garcia, F. Cruz-Talonia, J. Hernandez-Montes, B. Weiss-Steider, V. Ortiz-Navarrete, and A. Monroy-Garcia Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions J. Gen. Virol., September 1, 2004; 85(9): 2643 - 2650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Rosenblatt, J. J. Carter, L. M. Iwasaki, D. A. Galloway, and J. L. Stanford Serologic Evidence of Human Papillomavirus 16 and 18 Infections and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2003; 12(8): 763 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Davidson, P. Sehr, R. L. Faulkner, J. L. Parish, K. Gaston, R. A. Moore, M. Pawlita, H. C. Kitchener, and P. L. Stern Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia J. Gen. Virol., August 1, 2003; 84(8): 2089 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Varsani, A.-L. Williamson, D. de Villiers, I. Becker, N. D. Christensen, and E. P. Rybicki Chimeric Human Papillomavirus Type 16 (HPV-16) L1 Particles Presenting the Common Neutralizing Epitope for the L2 Minor Capsid Protein of HPV-6 and HPV-16 J. Virol., August 1, 2003; 77(15): 8386 - 8393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Y. Studentsov, G. Y. F. Ho, M. A. Marks, R. Bierman, and R. D. Burk Polymer-Based Enzyme-Linked Immunosorbent Assay Using Human Papillomavirus Type 16 (HPV16) Virus-Like Particles Detects HPV16 Clade-Specific Serologic Responses J. Clin. Microbiol., July 1, 2003; 41(7): 2827 - 2834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. Combita, A. Touze, L. Bousarghin, N. D. Christensen, and P. Coursaget Identification of Two Cross-Neutralizing Linear Epitopes within the L1 Major Capsid Protein of Human Papillomaviruses J. Virol., June 5, 2002; 76(13): 6480 - 6486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. I. White, S. D. Wilson, F. J. Palmer-Hill, R. M. Woods, S.-j. Ghim, L. A. Hewitt, D. M. Goldman, S. J. Burke, A. B. Jenson, S. Koenig, et al. Characterization of a Major Neutralizing Epitope on Human Papillomavirus Type 16 L1 J. Virol., June 1, 1999; 73(6): 4882 - 4889. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
